INS and metabolic disease: Accumulating evidence has demonstrated that the gut microbiota regulates host metabolism, such as diabetes, obesity, fatty liver disease, and enteropathy, suggesting a potential role for nutritional intervention to improve insulin sensitivity and glycemic control in individuals with metabolic diseases [18,19].